Anavex Life Sciences Corp (AVXL)
Anavex Life Sciences stock today
Anavex Life Sciences closed at $1.19 on October 30, 2026, down 8.46% on the day. Over the past year it returned -85.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $110 million.
| Period | AVXL | S&P 500 (SPY) |
|---|---|---|
| 1 month | -41.1% | -0.9% |
| 3 months | -55.9% | +2.1% |
| Year to date | -66.6% | +11.7% |
| 1 year | -85.2% | +12.4% |
| 3 years | -78.4% | +88.5% |
| 5 years | -93.6% | +76.0% |
Key statistics
- Market value
- $110M
- 52-week range
- $1.19 to $8.03
- Next report
- Nov 24, 2026 (estimated)
About Anavex Life Sciences
Develops small-molecule drug candidates for neurodegenerative and neuro-oncologic diseases.
Sector: Health Care
More on Anavex Life Sciences
- Returns: what $1,000 became$1,000 ten years ago is $402.03 today
No forecast, no recommendation. This page describes Anavex Life Sciences Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.